Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial.
Lancet (London, England), cilt.406, sa.10504, ss.695-704, 2025 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 406 Sayı: 10504
- Basım Tarihi: 2025
- Doi Numarası: 10.1016/s0140-6736(25)01198-5
- Dergi Adı: Lancet (London, England)
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, Abstracts in Social Gerontology, Aquatic Science & Fisheries Abstracts (ASFA), Artic & Antarctic Regions, BIOSIS, Business Source Elite, Business Source Premier, CAB Abstracts, CINAHL, Food Science & Technology Abstracts, Psycinfo, Public Affairs Index, Veterinary Science Database, Nature Index
- Sayfa Sayıları: ss.695-704
- Eskişehir Osmangazi Üniversitesi Adresli: Evet